Webinar Replay: Part 1: iRECIST: New Guidelines for Oncology Tumor Assessment

iRECIST guidelines have been developed to capture this new response pattern. This presentation, Part 1 of 2 presentations, will introduce you to the history of the iRECIST guidelines, the iRECIST process and how iRECIST is being used in oncology clinical trials. Part 2 will consist of a workshop using hypothetical cases to determine iRECIST responses.